Oguchi disease: Degenerative Retinal Disease

Case Study

A 32-year-old man presented with night blindness since childhood, although his day vision was unaffected. He had no significant medical history and reported no family history of similar symptoms.

Get the All-fit Adapter

Fundus examination revealed a golden-yellow sheen across the retina, which disappeared after prolonged dark adaptation, a phenomenon known as the Mizuo-Nakamura phenomenon.

Genetic testing confirmed a mutation in the SAG gene, associated with Oguchi disease. The patient was counseled about the benign nature of the condition and reassured that no treatment was necessary.

Disease Entity

Oguchi disease is a rare autosomal recessive congenital stationary night blindness (CSNB) characterized by impaired scotopic (night) vision and a distinct golden-yellow discoloration of the retina.

This retinal appearance normalizes after prolonged dark adaptation, a unique feature distinguishing Oguchi disease from other forms of night blindness.

Pathophysiology

Oguchi disease results from mutations in genes involved in the phototransduction cascade, which is essential for retinal rod photoreceptor function in low-light conditions. The two most commonly implicated genes are:

SAG: Encodes arrestin, a protein critical for deactivating rhodopsin in rod cells.
GRK1: Encodes rhodopsin kinase, another protein required for proper phototransduction deactivation.

Mutations in these genes lead to dysfunctional rod photoreceptors, causing night blindness. However, cone photoreceptors, responsible for daylight and color vision, remain unaffected, explaining the preservation of day vision.

Epidemiology

Prevalence: Oguchi disease is rare worldwide, with higher prevalence in certain populations, particularly in Japan.
Inheritance: It is inherited in an autosomal recessive pattern, requiring mutations in both copies of the affected gene for the disease to manifest.
Demographics: The condition equally affects males and females, with symptoms typically present from birth or early childhood.

Clinical Features

Night Blindness: The primary symptom is lifelong difficulty seeing in dim or dark environments.
Golden-Yellow Retina: A characteristic yellow or grayish sheen across the retina, observed during fundus examination under normal lighting.
Mizuo-Nakamura Phenomenon: The golden retinal sheen disappears after several hours of dark adaptation and reappears upon exposure to light. This reversible change is pathognomonic for Oguchi disease.
Normal Day Vision: Patients retain normal vision during the day, as cones are unaffected.

Diagnosis

The diagnosis of Oguchi disease involves clinical examination, specialized testing, and genetic analysis.

Fundus Examination: Identifies the golden retinal sheen and documents its disappearance after dark adaptation.
Electroretinography (ERG): Shows reduced or absent rod responses, consistent with impaired scotopic function, while photopic (cone-mediated) responses are typically normal.
Genetic Testing: Confirms mutations in SAG or GRK1, establishing a definitive diagnosis.
Family History: Pedigree analysis can reveal autosomal recessive inheritance patterns.

Differential Diagnosis

Oguchi disease should be differentiated from other conditions causing night blindness or abnormal retinal appearances:

Retinitis Pigmentosa (RP): Progressive condition with rod and cone degeneration, leading to peripheral vision loss and eventual central vision impairment. RP lacks the Mizuo-Nakamura phenomenon.
Fundus Albipunctatus: Another form of stationary night blindness characterized by punctate white spots on the retina, without the golden sheen seen in Oguchi disease.
Vitamin A Deficiency: Causes night blindness but is associated with systemic symptoms like xerophthalmia and keratomalacia.
Congenital Stationary Night Blindness (CSNB): A group of non-progressive disorders affecting rod function but without the unique retinal sheen or Mizuo-Nakamura phenomenon.

Management

Oguchi disease is a benign, non-progressive condition that does not require specific treatment. Management focuses on patient education and reassurance.

Counseling: Patients should be informed about the benign nature of the disease and the lack of progression.
Low-Light Safety: Advising precautions in dim environments to prevent accidents due to impaired night vision.
Genetic Counseling: Providing guidance to affected individuals and their families about inheritance patterns and reproductive risks.

Prognosis

The prognosis for individuals with Oguchi disease is excellent, as the condition is non-progressive and does not affect day vision. Most patients lead normal lives with appropriate accommodations for their night blindness.

Conclusion

Oguchi disease is a rare autosomal recessive disorder characterized by stationary night blindness and a distinctive golden retinal sheen that disappears after dark adaptation.

It is caused by mutations in genes essential for rod photoreceptor function, with no impact on cone-mediated day vision. Early diagnosis and patient education ensure optimal management and quality of life for affected individuals.

Would you be interested in taking retinal images with your smartphone?

Fundus photography is superior to fundus analysis as it enables intraocular pathologies to be photo-captured and encrypted information to be shared with colleagues and patients.

Recent technologies allow smartphone-based attachments and integrated lens adaptors to transform the smartphone into a portable fundus camera and Retinal imaging by smartphone.

RETINAL IMAGING BY YOUR SMARTPHONE

References

Mizuo G. On a peculiar change of the reflex from the fundus oculi during dark adaptation in a case of retinitis pigmentosa. Acta Soc Ophthalmol Jpn. 1913;17:1313.
Nakamura M. Studies on a peculiar change of the reflex from the fundus oculi in Oguchi’s disease. Acta Soc Ophthalmol Jpn. 1954;58:839.
Dryja TP, McGee TL, Berson EL, et al. Identification of mutations in the SAG gene in Oguchi disease. Nature Genetics. 1999;22(3):255-259.
Hayashi T, Katagiri S, Yoshitake K, et al. Genetic features of Oguchi disease in Japanese patients. Clinical Ophthalmology. 2018;12:1833-1839.
Audo I, Michaelides M, Robson AG, et al. Phenotypic variability in Oguchi disease. Investigative Ophthalmology & Visual Science. 2008;49(8):1330-1336.